title: High-affinity no-carrier-added 99mTc-labeled chemotactic peptides for studies of inflammation in vivo.
abstract: Nalpha-for-Nle-Leu-Phe-Nle-Tyr-Lys, a chemotactic peptide that binds with high affinity to the chemoattractant receptor on granulocytes and monocytes, was labeled with 99mTc using the diaminedithiol (DADT) chelating system to coordinate the Tc. 99mTc labeling of the DADT-coupled peptide was accomplished in 84% overall yield (room temperature for 10 min) using [99mTc]glucoheptonate as the donor of prereduced Tc. HPLC analysis showed two major 99mTc-labeled peptide peaks, 99mTc-DADT-Pep-I and 99mTc-DADT-Pep-II, were obtained in a ratio of 1:0.85. Using an iodoacetamide-derivatized gel to remove unlabeled peptide from the 99mTc labeling mixtures, essentially no-carrier-added (nca) high-specific activity 99mTc-labeled chemotactic peptides were obtained. The 99Tc analogues of the peptides were synthesized (72% yield) in a similar fashion and correlated with 99mTc complexes I and II by HPLC. In vitro competitive receptor binding assays of the isolated 99Tc analogues were performed against the tritiated chemotactic peptide [3H]N-for-Met-Leu-Phe ([3H]fMLF) using isolated granulocytes. The 99Tc-derivatized peptides showed similar binding affinities to the chemoattractant receptor as the unlabeled Nalpha-for-Nle-Leu-Phe-Nle-Tyr-Lys. The nca 99mTc-labeled peptides gave high contrast images of experimental inflammation in rabbits without causing neutropenia. Thus, it is feasible to attach the Tc-DADT chelate to low-molecular weight receptor binding chemotactic peptides and retain substantial binding to the receptor. Chemotactic peptides labeled with 99mTc via the DADT ligand system have the potential for imaging focal sites of inflammation without toxic effects, an important consideration in the successful utilization of chemotactic peptide agonists.
authors.affiliation: Department of Environmental Health Sciences, The Johns Hopkins University, Baltimore, Maryland 21205, USA. kbaidoo@jhsph.edu
authors.forename: K E
authors.initials: KE
authors.lastname: Baidoo
authors.forename: U
authors.initials: U
authors.lastname: Scheffel
authors.forename: M
authors.initials: M
authors.lastname: Stathis
authors.forename: P
authors.initials: P
authors.lastname: Finley
authors.forename: S Z
authors.initials: SZ
authors.lastname: Lever
authors.forename: Y
authors.initials: Y
authors.lastname: Zhan
authors.forename: H N
authors.initials: HN
authors.lastname: Wagner
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001667:Binding, Competitive; D002614:Chelating Agents; D002630:Chemotactic Factors / Q000737:chemistry / Q000633:toxicity; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D007249:Inflammation / Q000000981:diagnostic imaging*; D007553:Isotope Labeling; D007958:Leukocyte Count; D008297:Male; D051379:Mice; D015394:Molecular Structure; D009000:Monocytes / Q000378:metabolism; D009942:Organometallic Compounds / Q000737:chemistry / Q000633:toxicity; D011817:Rabbits; D011877:Radionuclide Imaging; D044042:Receptors, Formyl Peptide; D011971:Receptors, Immunologic / Q000378:metabolism; D018000:Receptors, Peptide / Q000378:metabolism; D013329:Structure-Activity Relationship; D014316:Tritium
chemical_list: D002614:Chelating Agents; D002630:Chemotactic Factors; D009942:Organometallic Compounds; D044042:Receptors, Formyl Peptide; D011971:Receptors, Immunologic; D018000:Receptors, Peptide; C112051:technetium Tc 99m diaminedithiol; D014316:Tritium